Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes

Area of Science:

• Mitochondrial biology
• Diabetes complications
• Metabolic diseases

Background:

• Diabetic peripheral neuropathy (DPN), diabetic kidney disease (DKD), and diabetic retinopathy (DR) are major causes of morbidity and mortality in type 2 diabetes (T2D).
• Current therapies offer limited impact on the pathogenesis of these T2D complications.
• Tissue-specific mitochondrial adaptations in T2D are known, but their causal role in dysfunction is unclear.

Purpose of the Study:

• To investigate the therapeutic potential of mitochondrial uncoupling using niclosamide ethanolamine (NEN) in T2D.
• To determine the effects of NEN on the development of T2D and its complications (DPN, DKD, DR) in a mouse model.

Main Methods:

• BKS-db/db mice, a model for T2D, were treated with NEN from 6 to 24 weeks of age.
• Evaluated the impact of NEN treatment on T2D progression and the development of DPN, DKD, and DR.

Main Results:

• NEN treatment showed minimal effect on the development of T2D.
• NEN treatment did not significantly alter the progression of DPN, DKD, or DR.
• Global mitochondrial uncoupling did not provide therapeutic benefit for the studied diabetic complications.

Conclusions:

• Targeting mitochondria globally with an uncoupling agent like NEN is unlikely to be an effective therapeutic strategy for DPN, DKD, or DR in T2D.
• Further research is needed to understand tissue-specific metabolic reprogramming in the pathogenesis of diabetic complications.